Business Wire1d
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapav…
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Gilead Withdraws Bladder Cancer Drug in US After Failed Trial
(Reuters) -Gilead Sciences said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of ...
Benzinga.com17d
Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
Gilead Sciences GILD underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their ...
Reuters17d
Gilead to donate remdesivir for emergency use against Marburg disease in Rwanda
Oct 3 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda Medical Supply for emergency use in ...
AllAfrica.com17d
Rwanda: Marburg Virus - Gilead Confirms Remdesivir Drug Donation to Rwanda
American biopharmaceutical company Gilead Sciences, on Thursday, October 3, announced that it will donate about 5,000 vials of its antiviral drug Remdesivir for emergency use in response to the ...
Business Insider17d
How Netflix's 'Nobody Wants This' was inspired by creator Erin Foster's real-life love story
But "Nobody Wants This" still manages to feel plausible and relatable — and that's because it's loosely based on creator Erin Foster's own experience falling in love with her husband ...
The Financial Express17d
Dr. Reddy’s enters into licensing agreement with Gilead Sciences for HIV drug
(Image Credits: Pixabay) Dr. Reddy’s Laboratories Ltd. on Wednesday announced that it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead Sciences Ireland UC ...
Business Line17d
Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application
Six drugmakers have inked voluntary licensing (VL) agreements with Gilead Sciences to manufacture and distribute generic lenacapavir, a long-acting injectable HIV drug from the American drugmaker.
ProPakistani18d
Ferozsons Partners With Gilead Sciences to Produce HIV Medicine in Pakistan
Ferozsons Laboratories Limited (PSX: FEROZ) has entered into a non-exclusive voluntary license agreement with Gilead Sciences Ireland ... with headquarters in Foster City, California If you ...
The Jamaica Observer18d
Gilead licenses HIV-prevention drug to generic drugmakers
This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, California, USA. The US government announced Tuesday June 30, 2020, that President Donald Trump had ...
BioSpace18d
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for treating human immunodeficiency virus in heavily pre-treated adults with ...
HUB18d
Designs for new Johns Hopkins Life Sciences Building presented to city planners
The latest designs of a new Life Sciences Building on the Johns Hopkins East Baltimore medical campus were presented today to the Baltimore City Urban Design & Architecture ... to speed the pace of ...